Xcell Therapeutics, Inc. (373110) Price & Analysis

― Followers

373110 Stock Chart & Stats

₩1007.00

-₩9.00(-0.89%)

Sep 14, 2026

―

Day’s Range― - ―

52-Week Range₩951.00 - ₩3,553.12

Previous CloseN/A

VolumeN/A

Average Volume (3M)360.23K

Market Cap

₩17.57B

Enterprise Value₩21.93K

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta0.23

Next Earnings

Nov 13, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-159.68

Shares Outstanding17,294,394

10 Day Avg. Volume145,815

30 Day Avg. Volume360,229

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Xcell Therapeutics, Inc. News

Xcell Therapeutics Trims Board as Independent Director Resigns

Xcell Therapeutics, Inc. ( ($KR:373110) ) just unveiled an announcement. Xcell Therapeutics has reported the voluntary resignation of...

5d ago

373110 FAQ

What was Xcell Therapeutics, Inc.’s price range in the past 12 months?

Xcell Therapeutics, Inc. lowest stock price was ₩951.00 and its highest was ₩3553.12 in the past 12 months.

What is Xcell Therapeutics, Inc.’s market cap?

Xcell Therapeutics, Inc.’s market cap is ₩17.57B.

When is Xcell Therapeutics, Inc.’s upcoming earnings report date?

Xcell Therapeutics, Inc.’s upcoming earnings report date is Nov 13, 2026 which is in 58 days.

How were Xcell Therapeutics, Inc.’s earnings last quarter?

Xcell Therapeutics, Inc. released its earnings results on Aug 06, 2026. The company reported -₩159.676 earnings per share for the quarter.

Is Xcell Therapeutics, Inc. overvalued?

According to Wall Street analysts Xcell Therapeutics, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Xcell Therapeutics, Inc. pay dividends?

Xcell Therapeutics, Inc. does not currently pay dividends.

What is Xcell Therapeutics, Inc.’s EPS estimate?

Xcell Therapeutics, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Xcell Therapeutics, Inc. have?

Xcell Therapeutics, Inc. has 17,294,394 shares outstanding.

What happened to Xcell Therapeutics, Inc.’s price movement after its last earnings report?

Xcell Therapeutics, Inc. reported an EPS of -₩159.676 in its last earnings report. Following the earnings report the stock price went up 4.983%.

Which hedge fund is a major shareholder of Xcell Therapeutics, Inc.?

Currently, no hedge funds are holding shares in KR:373110

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology